摘要:
The invention relates to a phosphor composition for lamps with a lattice of monoclinic crystal structure (monazite) of type (1−g)[((1−c−a)*Ln, c*Ce, a*A)PO4]×g*GeO2, in which Ln is at least one element selected from the group consisting of lanthanum La, gadolinium Gd and/or Yttrium Y and A is at least one activator selected from the group consisting of terbium Tb, praseodymium Pr and/or europium Eu, and 0≦a≦1.0; 0≦c≦1.0, and 0
摘要翻译:本发明涉及具有(1-g)[((1-ca)* Ln,c * Ce,a * A)PO 4的单斜晶体结构(独居石)晶格的灯的荧光体组合物, 其中Ln是选自镧La,钆Gd和/或钇Y中的至少一种元素,并且A是至少一种选自以下的活化剂: 由铽Tb,Pr镨Pr和/或铕Eu组成的组,0 <= a <= 1.0; 0 <= c <= 1.0,0
摘要:
A process for preparing a zeolitic material, comprising (i) preparing a mixture comprising the at least one silicon containing precursor compound from which the zeolitic framework is formed, at least one pore forming agent, and at least one polymer which has an essentially spheroidal geometry in the mixture; (ii) crystallizing the zeolitic material from the mixture obtained in (i) to obtain the crystallized zeolitic material in its mother liquor.
摘要:
A method and a corresponding device for optimising a cellular telecommunication network are provided. According to the provided method, an emulating device is connected to the cellular telecommunication network, thus creating a signalling link between the emulating device and the cellular telecommunication network. With the emulating device, functionalities of elements of the cellular telecommunication network are emulated and data traffic is created to an air interface of the cellular telecommunication network. The effects of created data traffic on the cellular telecommunication network are then measured and the cellular telecommunication network is adjusted on the basis of the measurements.
摘要:
The invention relates to a phosphor composition for lamps with a lattice of monoclinic crystal structure (monazite) of type (1−g)[((1−c−a)*Ln, c*Ce, a*A)PO4]×g*GeO2, in which Ln is at least one element selected from the group consisting of lanthanum La, gadolinium Gd and/or Yttrium Y and A is at least one activator selected from the group consisting of terbium Tb, praseodymium Pr and/or europium Eu, and 0≦a≦1.0; 0≦c≦1.0, and 0
摘要翻译:本发明涉及具有(1-g)[((1-ca)* Ln,c * Ce,a * A)PO 4的单斜晶体结构(独居石)晶格的灯的荧光体组合物, 其中Ln是选自镧La,钆Gd和/或钇Y中的至少一种元素,并且A是至少一种选自以下的活化剂: 由铽Tb,Pr镨Pr和/或铕Eu组成的组,0 <= a <= 1.0; 0 <= c <= 1.0,0
摘要:
Process for producing a phosphate of the lanthanoids, and phosphate produced thereby The process for producing a phosphate of the lanthanoids is based on a two-jet precipitation, starting from separate reservoirs of RE nitrate and phosphate which mix to form an initial charge.
摘要:
The present invention relates to a gauze catalyst based on titanium or vanadium zeolites and inert gauze fabrics which is suitable for accelerating oxidation reactions such as epoxidation of olefins, hydrogen peroxide production or hydroxylamine synthesis.
摘要:
The bicyclic heterocyclic compounds are prepared by reaction of correspondingly substituted carboxylic acids with amines, in particular with phenylglycinolamine. The bicyclic heterocyclic compounds according to the invention are suitable as active compounds in medicaments, in particular in medicaments having an antiatherosclerotic action.
摘要:
An oxidation catalyst based on titanium silicalites or vanadium silicalites having a zeolite structure and containing from 0.01 to 30% by weight of one or more noble metals selected from the group consisting of ruthenium, rhodium, palladium, osmium, iridium, platinum, rhenium, gold and silver has been molded by a compacting shaping process.This oxidation catalyst is used for the preparation of epoxides, in particular propylene oxide, from olefins, hydrogen and oxygen.
摘要:
The heterocyclic aryl-, alkyl- and cycloalkylacetamides are prepared by reacting the appropriately substituted acetic acids with amines, if appropriate in complexed form. The heterocyclic aryl-, alkyl- and cycloalkylacetamides can be used as active compounds in medicaments, in particular in antiatherosclerotic medicaments.
摘要:
Amides and sulphonamides of benzylamines having heterocyclic substituents are prepared by first converting the corresponding carboxylic acids into the corresponding amines and then substituting these on the amine nitrogen in a corresponding manner. The new amides and sulphonamides of benzylamines having heterocyclic substituents can be used as active compounds in medicaments, in particular in antiatherosclerotic medicaments.